Former Boston Scientific executive appointed CEO of PE-backed Collagen Matrix

Collagen Matrix, acquired by private equity firm Linden Capital Partners last year, appointed Shawn McCarthy as CEO on Jan. 29.

Advertisement

The company develops collagen and mineral-based products for tissue repair and regeneration, which has applications across the spine, neurosurgery and orthopedic markets.

Mr. McCarthy has more than 30 years of experience in the medical device industry.

Most recently he operated as general manager of structural heart valves at Boston Scientific, where he was responsible for developing products and acquiring new technologies.

Mr. McCarthy also served in leadership roles at Johnson & Johnson and Tryton Medical.

More articles on devices:
Bundled payments in spine: 12 key thoughts for 2020
Breaking down the 3 major robots in spine surgery
8 spine, neurosurgeon moves

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.